bioclusters_logo_plus_vertical

ESCP on Personalised Healthcare
bioXclusters plus

Emilien Voldoire
Head of European Affairs

Overview

Profile:
100% completed
Type of partnership
Target countries
Start of partnership
Partnership duration (months)
Number of partners
Number of SMEs involved

Summary and objectives

The bioXclusters+ alliance, supported from 2016 to 2018, gathers 4 European Life Sciences / health clusters: Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont), Lyonbiopole (Auvergne Rhone-Alpes). It aims to address the next-decade European challenges related to healthcare and SMEs growth, thanks to a common vision of personalised healthcare as the paradigm for future global healthcare solutions. To address this new paradigm, the bioXclusters+ partnership intends to be the most competitive European meta-cluster initiative in personalised healthcare, delivering at global level cutting edge solutions through its innovation ecosystem and offering an entry point for global players to Europe. In this regard, the consortium internationalisation strategy plan to focus their activities on three countries already explored (US, China and Brazil) but also on additional markets such as Japan. The approach consists in confirming its position at European and international scene in gaining visibility inside and outside Europe; reinforcing trustful relations with target countries building Gateways; deploy common internationalisation tools and tailored supported to European SMEs based on the mutual competence knowledge and long term relationship developed within the alliance. Furthermore the alliance will focus their action on addressing the challenges related to the global healthcare sector, such as the inclusion of technologies such as big data, micro and nanotechnologies, ICT for the development of systemic and practical solutions addressing the industry competitiveness and the patients' needs. This is the reason why collaboration with other key players (such as other ESCPs and other EU initiatives) in the sector mentioned above will be deploy.

Results expected

Signature of MoUs and gateways agreements with third countries

Organisation of C2C and B2B meetings

Organisation of inbound and outbound missions

Increase of collaborations with SMEs and external partners (technological and commercial agreements)

Sectorial and industrial focus

Sectoral industries
Human health and social work activities:Q86 Human health activities
Cross-sectoral industries
Biopharmaceuticals
Industrial Alliances and Ecosystems
Ecosystems:Health

Partnership composition

Other key partners or networks your partnership is linked with in Europe and in third countries

Country
Belgium
Name
CEBR
Country
Australia
Name
BioSA and Health Industries South Australia
Country
Japan
Name
Osaka Bio Headquarters
Country
South Korea
Name
Chuncheon Bioindustry Foundation
Country
China
Name
Fenglin Group
Country
Canada
Name
ToHealth!
Country
United States
Name
Wistar Institute
Profile name Location Network type

Upcoming events

Monday Tuesday Wednesday Thursday Friday Saturday Sunday
30
31
1
2
3
4
5
 
 
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
 
 
 

Latest news and documents

News Published: 11.07.2018
bioXclusters’ SMEs will benefit from a Strategic entry point to South Korean Health Market through the Incheon Bio Gateway - IFEZ: Incheon Free Economic Zone
Document Published: 04.06.2018
bioXclusters plus 2nd newsletter
Document Published: 04.06.2018
bioXclusters plus' newsletters
News Published: 01.06.2018
bioXclusters alliance flying to BIO Intl. Convention, Boston (from June 4 to 7, 2018)